- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of drug resistance: daptomycin resistance
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1354, Issue 1, Pages 32-53
Publisher
Wiley
Online
2015-10-25
DOI
10.1111/nyas.12948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of a strain of methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin 7 months after treatment with glycopeptide antibiotics
- (2016) Cheng Len Sy et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Characterization of High-Level Daptomycin Resistance in Viridans Group Streptococci Developed uponIn VitroExposure to Daptomycin
- (2015) Ronda L. Akins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Enhance Daptomycin Activity against Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium inIn VitroPharmacokinetic/Pharmacodynamic Models
- (2015) Jordan R. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci
- (2015) Janet A. Hindler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Staphylococcus aureus Metabolic Adaptations during the Transition from a Daptomycin Susceptibility Phenotype to a Daptomycin Nonsusceptibility Phenotype
- (2015) Rosmarie Gaupp et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Frequency and Distribution of Single-Nucleotide Polymorphisms withinmprFin Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides
- (2015) Arnold S. Bayer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A variable DNA recognition site organization establishes the LiaR-mediated cell envelope stress response of enterococci to daptomycin
- (2015) Milya Davlieva et al. NUCLEIC ACIDS RESEARCH
- The Lipid-Modifying Multiple Peptide Resistance Factor Is an Oligomer Consisting of Distinct Interacting Synthase and Flippase Subunits
- (2015) Christoph M. Ernst et al. mBio
- Impact of daptomycin resistance onStaphylococcus aureusvirulence
- (2015) David R Cameron et al. Virulence
- Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
- (2014) Lorena Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Heterogeneity ofmprFSequences in Methicillin-Resistant Staphylococcus aureus Clinical Isolates: Role in Cross-Resistance between Daptomycin and Host Defense Antimicrobial Peptides
- (2014) Arnold S. Bayer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis
- (2014) B. J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interaction of Daptomycin with Lipid Bilayers: A Lipid Extracting Effect
- (2014) Yen-Fei Chen et al. BIOCHEMISTRY
- Daptomycin forms cation- and size-selective pores in model membranes
- (2014) TianHua Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Failure of High-Dose Daptomycin for Bacteremia Caused by Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions
- (2014) Jose M. Munita et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin and Piperacillin-Tazobactam Against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
- (2014) Thomas J. Dilworth et al. CLINICAL THERAPEUTICS
- Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2014) Abhay Dhand et al. CLINICAL THERAPEUTICS
- Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale
- (2014) E. McElvania TeKippe et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Mechanisms of antibiotic resistance in enterococci
- (2014) William R Miller et al. Expert Review of Anti-Infective Therapy
- Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
- (2014) Jose M. Munita et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: Summary of 8 years of a Worldwide Surveillance Programme (2005–2012)
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE
- (2014) B. J. Werth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
- (2014) A. Hall Snyder et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
- (2014) K. E. Barber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin
- (2014) TianHua Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms of vancomycin resistance in Staphylococcus aureus
- (2014) Susana Gardete et al. JOURNAL OF CLINICAL INVESTIGATION
- A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis
- (2014) Jinnethe Reyes et al. JOURNAL OF INFECTIOUS DISEASES
- Subcellular localization, interactions and dynamics of the phage-shock protein-like Lia response inBacillus subtilis
- (2014) Julia Domínguez-Escobar et al. MOLECULAR MICROBIOLOGY
- Phenotypic and Genotypic Characterization of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Strains: Relative Roles of mprF and dlt Operons
- (2014) Nagendra N. Mishra et al. PLoS One
- β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureus
- (2013) Andrew D. Berti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AliaFCodon Deletion Abolishes Daptomycin Bactericidal Activity against Vancomycin-Resistant Enterococcus faecalis
- (2013) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S. aureus Strains in anIn VitroPharmacokinetic/Pharmacodynamic Model: Exploring the “Seesaw Effect”
- (2013) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Causal Role of Single Nucleotide Polymorphisms within themprFGene of Staphylococcus aureus in Daptomycin Resistance
- (2013) Soo-Jin Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adaptation of Enterococcus faecalis to Daptomycin Reveals an Ordered Progression to Resistance
- (2013) Corwin Miller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Vancomycin in Combination with Piperacillin-Tazobactam or Oxacillin against Clinical Methicillin-Resistant Staphylococcus aureus Isolates and Vancomycin-Intermediate S. aureus IsolatesIn Vitro
- (2013) Thomas J. Dilworth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EarlyIn VitroandIn VivoDevelopment of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin
- (2013) Cristina García-de-la-Mària et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
- (2013) M. E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- A Current Perspective on Daptomycin for the Clinical Microbiologist
- (2013) R. M. Humphries et al. CLINICAL MICROBIOLOGY REVIEWS
- Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the “seesaw effect”: Taking advantage of the back door left open?
- (2013) Jessica K. Ortwine et al. DRUG RESISTANCE UPDATES
- dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus
- (2013) Viviana Cafiso et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis
- (2013) Laurent Dortet et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome
- (2013) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Changes in Psp protein binding partners, localization and behaviour upon activation of theYersinia enterocoliticaphage shock protein response
- (2013) Saori Yamaguchi et al. MOLECULAR MICROBIOLOGY
- Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates
- (2013) Ute Bertsche et al. PLoS One
- Emergence of Daptomycin Resistance in Daptomycin-Naïve Rabbits with Methicillin-Resistant Staphylococcus aureus Prosthetic Joint Infection Is Associated with Resistance to Host Defense Cationic Peptides and mprF Polymorphisms
- (2013) Nagendra N. Mishra et al. PLoS One
- Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids
- (2013) T. T. Tran et al. mBio
- Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall
- (2012) Arnold S. Bayer et al. Annals of the New York Academy of Sciences
- Native Valve Endocarditis Caused by Corynebacterium striatum with Heterogeneous High-Level Daptomycin Resistance: Collateral Damage from Daptomycin Therapy?
- (2012) Truc T. Tran et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Novel Combination of High-Dose Daptomycin plus Trimethoprim-Sulfamethoxazole against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Using anIn VitroPharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations
- (2012) Molly E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Whole-Genome Analysis of a Daptomycin-Susceptible Enterococcus faecium Strain and Its Daptomycin-Resistant Variant Arising during Therapy
- (2012) Truc T. Tran et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in anIn VitroPharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2012) Ashley D. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Therapy with Ampicillin and Daptomycin for Treatment of Enterococcus faecalis Endocarditis
- (2012) M. Sierra-Hoffman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis
- (2012) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biochemical Characterization of Cardiolipin Synthase Mutations Associated with Daptomycin Resistance in Enterococci
- (2012) Milya Davlieva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus
- (2012) C. Garrigós et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity
- (2012) Warren E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics
- (2012) Andrew D. Berti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faecium
- (2012) Romney M. Humphries et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment
- (2012) Pamela A. Moise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
- (2012) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alanyl-Phosphatidylglycerol and Lysyl-Phosphatidylglycerol Are Translocated by the Same MprF Flippases and Have Similar Capacities To Protect against the Antibiotic Daptomycin in Staphylococcus aureus
- (2012) Christoph J. Slavetinsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation of Cell Membrane Lipid Profiles with Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus
- (2012) N. N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation between Mutations inliaFSRof Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
- (2012) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Case-Control Study ComparingDe Novoand Daptomycin-Exposed Daptomycin-Nonsusceptible Enterococcus Infections
- (2012) Theodoros Kelesidis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Estimation of the subunit stoichiometry of the membrane-associated daptomycin oligomer by FRET
- (2012) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Alternative cardiolipin synthase Cls1 compensates for stalled Cls2 function inStaphylococcus aureusunder conditions of acute acid stress
- (2012) Ryosuke L. Ohniwa et al. FEMS MICROBIOLOGY LETTERS
- Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
- (2012) S. N. Leonard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins
- (2012) J. Pogliano et al. JOURNAL OF BACTERIOLOGY
- The Tat System for Membrane Translocation of Folded Proteins Recruits the Membrane-stabilizing Psp Machinery inEscherichia coli
- (2012) Denise Mehner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates ofStaphylococcus aureuswith mutations inmprF
- (2012) Aileen Rubio et al. MOLECULAR MEMBRANE BIOLOGY
- Stoichiometry and perturbation studies of the LiaFSR system ofBacillus subtilis
- (2012) Karen Schrecke et al. MOLECULAR MICROBIOLOGY
- Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus
- (2012) Anton Y. Peleg et al. PLoS One
- Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content
- (2012) Nagendra N. Mishra et al. PLoS One
- Breakthrough Bacteremia and Septic Shock Due to Streptococcus anginosus Resistant to Daptomycin in a Patient Receiving Daptomycin Therapy
- (2011) Federico Palacio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterizing Vancomycin-Resistant Enterococcus Strains with Various Mechanisms of Daptomycin Resistance Developed in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Molly E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Striking “Seesaw Effect” between Daptomycin Nonsusceptibility and β-Lactam Susceptibility in Staphylococcus haemolyticus
- (2011) Carla Vignaroli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2011) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Basis for Daptomycin Resistance in Enterococci
- (2011) Kelli L. Palmer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
- (2011) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduction in Membrane Phosphatidylglycerol Content Leads to Daptomycin Resistance in Bacillus subtilis
- (2011) Anna-Barbara Hachmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation of Daptomycin Resistance in a ClinicalStaphylococcus aureusStrain with Increased Cell Wall Teichoic Acid Production and d-Alanylation
- (2011) Ute Bertsche et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus
- (2011) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oligomerization of daptomycin on membranes
- (2011) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Characterization of daptomycin oligomerization with perylene excimer fluorescence: Stoichiometric binding of phosphatidylglycerol triggers oligomer formation
- (2011) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach
- (2011) Adrien Fischer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of Staphylococcus aureus Cardiolipin Synthases 1 and 2 and Their Contribution to Accumulation of Cardiolipin in Stationary Phase and within Phagocytes
- (2011) T. Koprivnjak et al. JOURNAL OF BACTERIOLOGY
- Multiple Peptide Resistance Factor (MprF)-mediated Resistance ofStaphylococcus aureusagainst Antimicrobial Peptides Coincides with a Modulated Peptide Interaction with Artificial Membranes Comprising Lysyl-Phosphatidylglycerol
- (2011) Jörg Andrä et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids
- (2011) Christoph M. Ernst et al. MOLECULAR MICROBIOLOGY
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
- (2011) Benjamin P. Howden et al. PLoS Pathogens
- Successful Treatment of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus Aureus Bacteremia with the Addition of Rifampin to Daptomycin
- (2010) Nasir M Ahmad et al. ANNALS OF PHARMACOTHERAPY
- Regulation ofmprFby Antisense RNA Restores Daptomycin Susceptibility to Daptomycin-Resistant Isolates ofStaphylococcus aureus
- (2010) Aileen Rubio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Daptomycin Nonsusceptibility with Heterogeneous Vancomycin-Intermediate Resistance and Oxacillin Susceptibility in Methicillin-Resistant Staphylococcus aureus during High-Dose Daptomycin Treatment
- (2010) C.-H. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations
- (2010) M. E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carotenoid-Related Alteration of Cell Membrane Fluidity ImpactsStaphylococcus aureusSusceptibility to Host Defense Peptides
- (2010) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature
- (2010) S. J. van Hal et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin
- (2010) José M. Entenza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In-Depth Profiling of the LiaR Response of Bacillus subtilis
- (2010) D. Wolf et al. JOURNAL OF BACTERIOLOGY
- Daptomycin versus Friulimicin B: In-Depth Profiling of Bacillus subtilis Cell Envelope Stress Responses
- (2009) T. Wecke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
- (2009) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Analysis of Factors Affecting Susceptibility of Bacillus subtilis to Daptomycin
- (2009) A.-B. Hachmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus
- (2009) N. N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Balancing Act: Microbe versus Muscle
- (2009) Sara E. Cosgrove et al. CLINICAL INFECTIOUS DISEASES
- Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies
- (2009) J. N. Steenbergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Life-Threatening Infection Caused by Daptomycin-Resistant Corynebacterium jeikeium in a Neutropenic Patient
- (2009) C. Schoen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureus
- (2009) Soo‐Jin Yang et al. JOURNAL OF INFECTIOUS DISEASES
- The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
- (2009) Christoph M. Ernst et al. PLoS Pathogens
- Serial Daptomycin Selection Generates Daptomycin-Nonsusceptible Staphylococcus aureus Strains with a Heterogeneous Vancomycin-Intermediate Phenotype
- (2008) I. L. B. d. C. Camargo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phenotypic and Transcriptomic Characterization of Bacillus subtilis Mutants with Grossly Altered Membrane Composition
- (2008) L. I. Salzberg et al. JOURNAL OF BACTERIOLOGY
- Bacitracin sensing in Bacillus subtilis
- (2008) Eva Rietkötter et al. MOLECULAR MICROBIOLOGY
- A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway
- (2008) Sarah Dubrac et al. MOLECULAR MICROBIOLOGY
- A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
- (2008) C.-I Liu et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now